Long-Lived plasma cells: mysterious sentinels and persistent IgE producers?

Long-lived plasma cells (LLPCs) constitute a specialized and durable arm of humoral memory. While their role in maintaining long-term IgG and IgA immunity is firmly established, their contribution to IgE-mediated allergic disease remains clinically unproven. Nevertheless, recent advances in LLPC biology-accelerated substantially since 2021-have shown that IgE⁺ LLPC-like cells do exist in human bone marrow and chronically inflamed tissues, providing an immunological basis for exploring their potential involvement in persistent sensitization. LLPCs arise through tightly orchestrated developmental programs and rely on survival niches shaped by stromal cells, cytokines and metabolic adaptations. These features allow continuous antibody secretion for years or decades, independently of antigen re-exposure. Their metabolic resilience and resistance to apoptosis make them among the most durable effector cells in adaptive immunity. In parallel, several mechanisms already known to support IgE persistence-early-life programming of type-2 responses, Treg/Tfr disequilibrium, sequential class switching from IgG1 memory, and rapid recall from non-IgE memory B cells-form a robust framework capable of sustaining long-term allergic sensitization irrespective of LLPC involvement. Within this architecture, the confirmed presence of IgE⁺ long-lived plasma cells offers a biologically plausible, though not yet clinically validated, explanation for the remarkable stability of IgE profiles observed in many allergic conditions. Considering LLPCs within the broader context of IgE persistence highlights an area of growing immunological relevance while underscoring that their precise contribution to allergic disease remains to be determined.